It's just that such a small population is looking / able to buy this stock. Investment firms have started tracking the stock, but they can't do anything as it is too risky. They need to show profit and growth in sales.
If/when they get the approval for treatment of opiate addiction after they have already begun to pull a profit, then I think this will realistically top $10 within the following 2 quarters after that (small percentage growth per day with some big jumps in the middle).
Already been here 2.5 years...why not 2.5 more >:| 2.5 more being the time it'll probably take to get to $10-$20 range. After that they should qualify to be on Nasdaq and that'll again give them a major major boost (assuming there are no significant threats to the business or the revenue streams).
News 
Market Data 
Discover 
